Spelling suggestions: "subject:"fibular""
11 |
Lower leg reconstruction after resection of a squamous cell carcinoma on necrobiosis lipoidica with a pedicled fibula and an extended anterolateral thigh flap: a case reportBota, Olimpiu, Meier, Friedegund, Garzarolli, Marlene, Schaser, Klaus‑Dieter, Dragu, Adrian, Taqatqeh, Feras, Fritzsche, Hagen 06 November 2024 (has links)
Background
Extensive loss of soft tissue and bone due to neoplasia, trauma, or infection in extremities often leads to amputation.
Case presentation
We present the case of a 72-year-old female patient presenting with an extended cutaneous squamous cell carcinoma of the lower leg, developed on top of necrobiosis lipoidica. After achieving the R0 resection, a 26 × 20-cm soft tissue and 15-cm tibial bone defect resulted. The contralateral leg had been lost due to the same disease 18 years before. We achieved a successful reconstruction of the leg using a pedicled fibula transplantation, an extended anterolateral thigh perforator flap, and an internal fixation with plate and screws. Two years after the original surgery, the patient is relapse-free and mobile, with adequate function of the reconstructed foot.
Conclusions
Our case presented a unique combination of pedicled fibula transplantation and free extended ALT perforator flap to reconstruct an extensive defect after resection of a rare cSCC on top of NL. In selected cases, the boundaries of limb salvage can be pushed far beyond the current standards of treatment.
|
12 |
The non-operative treatment of Weber B -type ankle fractures and the clinical relevance and treatment of syndesmosis injuryKortekangas, T. (Tero) 24 October 2017 (has links)
Abstract
Despite numerous biomechanical and clinical studies on ankle fractures, the optimal treatment method for a stable fibula fracture is poorly known. Additionally, the clinical relevance and optimal fixation method of syndesmosis injury for different ankle fracture types is unclear.
This thesis aimed: (I) to compare six weeks of cast immobilization with three weeks of immobilization (cast or orthosis) in a randomized controlled trial (RCT) of 247 patients with stable Weber B-type fibular fracture; (II) to compare mid-term outcome of syndesmosis transfixation with no fixation in an RCT of 24 patients with supination external rotation (SER) ankle fractures and syndesmosis injury; (III) to evaluate the significance of the syndesmosis injury on clinical outcome in a case-control study of 48 patients with SER ankle fractures; and (IV) to compare the syndesmosis fixation with a screw versus a suture-button device in terms of the accuracy and the maintenance of syndesmosis reduction in an RCT of 43 patients with pronation external rotation (PER) ankle fractures.
Three weeks of immobilization in either a cast or an orthosis resulted in non-inferior outcomes compared to traditional six weeks’ immobilization in patients with stable Weber B-type fibula fracture. In patients with SER ankle fracture and unstable syndesmosis after fixation of bone fractures, leaving unstable syndesmosis unfixed resulted in similar outcomes compared to syndesmosis transfixation at mid-term follow-up. Patients with SER ankle fractures with or without an associated syndesmosis injury had similar clinical outcomes after a minimum of four years of follow-up. The syndesmotic screw and the suture-button fixation in patients with PER ankle fracture and unstable syndesmosis resulted in a low malreduction rate and both methods maintained reduction well.
In conclusion, stable Weber B-type fibula fractures can safely be treated with only three weeks of cast immobilization or even with a simple orthosis. A syndesmosis injury in SER ankle fractures seems to be of minor therapeutic or prognostic importance and syndesmosis screw fixation has no effect on patient’s recovery compared to no syndesmosis fixation. An associated syndesmosis injury in PER ankle fractures can be fixed with a syndesmotic screw or a suture-button device with comparable outcomes. / Tiivistelmä
Stabiilin nilkkamurtuman konservatiivisen hoidon toteutuksesta on hyvälaatuista tutkimustietoa tarjolla niukasti. Syndesmoosivamman kliininen merkitys ja sen hoitomenetelmät eri nilkkamurtumatyypeissä ovat kirjallisuuden perusteella vielä osittain epäselvät.
Ensimmäisessä osatyössä vertailtiin kolmen viikon immobilisaatiota (kipsi tai ortoosi) perinteiseen kuuden viikon kipsihoitoon satunnaistetussa ja kontrolloidussa tutkimuksessa, joka käsitti 247 stabiilin Weber B-tyypin pohjeluun murtuman saanutta potilasta. Toisessa osatyössä vertailtiin syndesmoosin ruuvikiinnitystä kiinnittämättä jättämiseen satunnaistetussa ja kontrolloidussa tutkimuksessa, johon osallistui 24 SER (supinaatio-ulkorotaatio) -tyypin nilkkamurtumapotilasta, joilla todettiin syndesmoosin epävakaus leikkauksen aikaisessa rasituskokeessa. Kolmannessa osatyössä selvitettiin syndesmoosivamman kliinistä merkitystä SER-tyypin nilkkamurtumapotilailla tapaus-verrokki-asetelmassa. Neljännessä osatyössä vertailtiin syndesmoosin ruuvi- ja jännitelankakiinnitystä syndesmoosin kiinnitystarkkuuden ja kiinnityksen pysyvyyden suhteen satunnaistetussa ja kontrolloidussa tutkimuksessa, joka käsitti 43 PER (pronaatio-ulkorotaatio) -tyypin nilkkamurtuman saanutta potilasta.
Stabiilin Weber B-tyypin pohjeluun murtuman hoidossa kolmen viikon immobilisaatio joko kipsillä tai ortoosilla oli yhtä hyvä ja turvallinen kuin perinteinen kuuden viikon kipsihoito. Syndesmoosin ruuvikiinnitettyjen ja kiinnittämättä jätettyjen SER-tyypin nilkkamurtumapotilaiden hoitotuloksissa ei todettu merkittäviä eroja keskipitkän aikavälin seurannassa. Syndesmoosivammalla ei todettu merkitystä SER-tyypin nilkkamurtuma-potilaiden hoitotulokseen tai ennusteeseen vähintään neljän vuoden seurannan jälkeen. Syndesmoosin reduktion suhteen ruuvi- ja jännitelankakiinnityksellä saadaan yhtä hyvät varhaisvaiheen tulokset PER-tyypin nilkkamurtumapotilailla ja molemmat kiinnitysmenetelmät säilyttävät syndesmoosin reduktion hyvin.
Stabiilin Weber B -tyypin pohjeluun murtuman hoito voidaan toteuttaa turvallisesti ja tehokkaasti kolmen viikon immobilisaatiolla joko nilkkaortoosilla tai saapaskipsillä. Syndesmoosivammalla ei vaikuta olevan kliinistä merkitystä SER-tyypin nilkkamurtumapotilaan ennusteeseen, eikä vamman hoitaminen ruuvikiinnityksellä paranna potilaan hoitotulosta kiinnittämättä jättämiseen verrattuna. PER-tyypin nilkkamurtumiin liittyvän syndesmoosivamman korjauksessa voidaan käyttää joko ruuvikiinnitystä tai jännitelankasidosta yhtä hyvin hoitotuloksin.
|
13 |
Nerve guides manufactured from photocurable polymers to aid peripheral nerve repairPateman, C.J., Harding, A.J., Glen, A., Taylor, C.S., Christmas, C.R., Robinson, P.P., Rimmer, Stephen, Boissonade, F.M., Claeyssens, F., Haycock, J.W. 2015 February 1914 (has links)
Yes / The peripheral nervous system has a limited innate capacity for self-repair following injury, and surgical intervention is often required. For injuries greater than a few millimeters autografting is standard practice although it is associated with donor site morbidity and is limited in its availability. Because of this, nerve guidance conduits (NGCs) can be viewed as an advantageous alternative, but currently have limited efficacy for short and large injury gaps in comparison to autograft. Current commercially available NGC designs rely on existing regulatory approved materials and traditional production methods, limiting improvement of their design. The aim of this study was to establish a novel method for NGC manufacture using a custom built laser-based microstereolithography (muSL) setup that incorporated a 405 nm laser source to produce 3D constructs with approximately 50 mum resolution from a photocurable poly(ethylene glycol) resin. These were evaluated by SEM, in vitro neuronal, Schwann and dorsal root ganglion culture and in vivo using a thy-1-YFP-H mouse common fibular nerve injury model. NGCs with dimensions of 1 mm internal diameter x 5 mm length with a wall thickness of 250 mum were fabricated and capable of supporting re-innervation across a 3 mm injury gap after 21 days, with results close to that of an autograft control. The study provides a technology platform for the rapid microfabrication of biocompatible materials, a novel method for in vivo evaluation, and a benchmark for future development in more advanced NGC designs, biodegradable and larger device sizes, and longer-term implantation studies.
|
Page generated in 0.0384 seconds